Clinical Trial Update: Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anidulafungin versus fluconazole for prevention of fungal infections in liver transplant recipients. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungemia
• Invasive Fungal Infection

Drugs mentioned

• Diflucan (Fluconazole)
• Eraxis (anidulafungin)

Snippet

Sponsor: University of Pittsburgh | Conditions: Mycoses, Fungemia | Phase 4 | Status: COMPLETED | Results posted: 2014-12-17